Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) FCF Margin (2016 - 2025)

STRATA Skin Sciences' FCF Margin history spans 13 years, with the latest figure at 15.62% for Q3 2025.

  • For Q3 2025, FCF Margin fell 1148.0% year-over-year to 15.62%; the TTM value through Sep 2025 reached 11.34%, down 523.0%, while the annual FY2024 figure was 4.31%, 1229.0% up from the prior year.
  • FCF Margin for Q3 2025 was 15.62% at STRATA Skin Sciences, up from 24.53% in the prior quarter.
  • Across five years, FCF Margin topped out at 13.19% in Q2 2021 and bottomed at 34.48% in Q1 2023.
  • The 5-year median for FCF Margin is 11.0% (2025), against an average of 11.67%.
  • The largest YoY upside for FCF Margin was 2190bps in 2021 against a maximum downside of -3664bps in 2021.
  • A 5-year view of FCF Margin shows it stood at 5.09% in 2021, then crashed by -182bps to 14.34% in 2022, then soared by 72bps to 3.99% in 2023, then soared by 152bps to 2.08% in 2024, then tumbled by -851bps to 15.62% in 2025.
  • Per Business Quant, the three most recent readings for SSKN's FCF Margin are 15.62% (Q3 2025), 24.53% (Q2 2025), and 11.0% (Q1 2025).